This content is from: Premium

Health Care Specialist Launches New PE Fund

Cormorant Asset Management is the latest to raise a new fund targeting private life sciences and biopharma companies.

A little-known life sciences and biopharma hedge fund specialist is launching its fourth private equity fund.Cormorant Asset Management disclosed in a regulatory filing it has raised nearly $253 million from 34 investors for Cormorant Private Healthcare Fund IV.It is targeting a total of $400 million, according to the filing.The firm

To continue reading, subscribe now to Premium Journalism. Already a subscriber? Login.

Related Content